CCCC
C4 Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
CCCC fundamentals
C4 Therapeutics (CCCC) expects to report earnings on Aug 7, 2025, with estimated revenue of 5.24M (YoY -56.36%), and EPS at -0.38 (YoY -46.15%).
Revenue estimate / YoY
5.24M
-56.36%
EPS estimate / YoY
-0.38
-46.15%
Report date
Aug 7, 2025
EPS
Revenue
Revenue & Expenses
CCCC has released its 2025 Q1 earnings report, with revenue of 7.24M, reflecting a YoY change of 138.17%, and net profit of -26.32M, showing a YoY change of 7.19%. The Sankey diagram below clearly presents CCCC's revenue sources and cost distribution.
Key Indicators
C4 Therapeutics (CCCC) key financial stats and ratios, covering profitability, financial health, and leverage.
C4 Therapeutics (CCCC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
C4 Therapeutics (CCCC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
C4 Therapeutics (CCCC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does C4 Therapeutics (CCCC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track C4 Therapeutics (CCCC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for C4 Therapeutics year over year?What were the key takeaways from C4 Therapeutics’s earnings call?How were C4 Therapeutics’s latest financial results overall?What is the market’s earnings forecast for C4 Therapeutics next quarter?What does C4 Therapeutics do and what are its main business segments?What guidance did C4 Therapeutics’s management provide for the next earnings period? What is C4 Therapeutics’s gross profit margin?What factors drove the changes in C4 Therapeutics’s revenue and profit?